Theravance Biopharma Submits Investigational New Drug (IND) Application for TD-1473, a GI-Targeted Pan-Janus Kinase (JAK) ...
DUBLIN, IRELAND -- (Marketwired) -- 11/02/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it has submitted an investigational new drug (IND) application to the U.S. Food and …